Dr. Amirhossein Sahebkar received his PharmD and PhD (in Medical Biotechnology) degrees from the Mashhad University of Medical Sciences (MUMS; Mashhad, Iran). His research focuses on the investigation of novel natural products for the management of severe cardiometabolic disorders. He has conducted numerous research projects dealing with basic, experimental, and clinical research on curcuminoids. Thozhukat Sathyapalan (Sathya) is the academic lead for diabetes, endocrinology, and metabolism research in the Clinical Sciences Centre at the Hull York Medical School. He is also an Honorary Consultant Endocrinologist at Hull and East Yorkshire Hospitals NHS Trust, UK. His main area of research is on modulation of cardiovascular risk through pharmacological and nutritional interventions in insulin resistant states such as obesity, polycystic ovary syndrome (PCOS) and type 2 diabetes mellitus. He is interested in traditional as well as novel risk factors, specifically endocrine disruptors.